logo-loader

Lorus Therapeutics

Receive alerts
Market:
TSX
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Lorus is a clinical stage cancer drug development company with a strong commitment to discovering and developing innovative molecular targeted therapies addressing major unmet medical needs. Our focus is on cellular targets that are emerging on the leading edge of cancer research and not already widely developed. Our drug pipeline includes Small Molecule products and Immunotherapies that address novel validated cancer targets that spare normal tissue and therefore demonstrate high safety profiles.